RecruitingNot ApplicableNCT07283653

Dissemination and Implementation of DIGEST™ as an Evidence-based Measurement Tool for Dysphagia: A Randomized Implementation Trial

Sponsor

M.D. Anderson Cancer Center

Enrollment

85 participants

Start Date

Jun 1, 2025

Study Type

INTERVENTIONAL

Conditions

Dysphagia DIGEST Evidence Based Measurement Randomized Implementation

Summary

To improve swallowing outcomes in cancer through clinical implementation of the Dynamic Imaging Grade of Swallowing Toxicity (DIGEST™) as an evidence-based practice (EBP) tool to grade pharyngeal dysphagia (difficulty swallowing) as a toxicity of cancer.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying DIGEST Training + Practice Facilitation, DIGEST Training Program, and others for people with digest, dysphagia, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.